2024-03-01 2025-02-28 true No description of principal activity Capium Accounts Production 1.1 13182333 2024-03-01 2025-02-28 13182333 bus:FullAccounts 2024-03-01 2025-02-28 13182333 bus:FRS102 2024-03-01 2025-02-28 13182333 bus:AuditExemptWithAccountantsReport 2024-03-01 2025-02-28 13182333 bus:SmallCompaniesRegimeForAccounts 2024-03-01 2025-02-28 13182333 bus:PrivateLimitedCompanyLtd 2024-03-01 2025-02-28 13182333 2024-03-01 2025-02-28 13182333 2025-02-28 13182333 bus:RegisteredOffice 2024-03-01 2025-02-28 13182333 core:WithinOneYear 2025-02-28 13182333 core:AfterOneYear 2025-02-28 13182333 1 2024-03-01 2025-02-28 13182333 bus:Director1 2024-03-01 2025-02-28 13182333 bus:Director1 2025-02-28 13182333 bus:Director1 2023-03-01 2024-02-29 13182333 bus:Director2 2024-03-01 2025-02-28 13182333 bus:Director2 2025-02-28 13182333 bus:Director2 2023-03-01 2024-02-29 13182333 2023-03-01 13182333 bus:LeadAgentIfApplicable 2024-03-01 2025-02-28 13182333 2023-03-01 2024-02-29 13182333 2024-02-29 13182333 core:WithinOneYear 2024-02-29 13182333 core:AfterOneYear 2024-02-29 13182333 bus:EntityAccountantsOrAuditors 2023-03-01 2024-02-29 13182333 core:CostValuation core:Non-currentFinancialInstruments 2025-02-28 13182333 core:CostValuation core:Non-currentFinancialInstruments 2024-02-29 13182333 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-02-28 13182333 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-02-28 13182333 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-02-28 13182333 core:Non-currentFinancialInstruments 2025-02-28 13182333 core:Non-currentFinancialInstruments 2024-02-29 13182333 core:ShareCapital 2025-02-28 13182333 core:ShareCapital 2024-02-29 13182333 core:ShareCapitalOrdinaryShares 2024-03-01 13182333 core:ShareCapitalOrdinaryShares 2023-03-01 13182333 core:ShareCapitalOrdinaryShares 2024-03-01 2025-02-28 13182333 core:ShareCapitalOrdinaryShares 2023-03-01 2024-02-29 13182333 core:ShareCapitalOrdinaryShares 2025-02-28 13182333 core:ShareCapitalOrdinaryShares 2024-02-29 13182333 core:RetainedEarningsAccumulatedLosses 2024-03-01 13182333 core:RetainedEarningsAccumulatedLosses 2023-03-01 13182333 core:RetainedEarningsAccumulatedLosses 2024-03-01 2025-02-28 13182333 core:RetainedEarningsAccumulatedLosses 2023-03-01 2024-02-29 13182333 core:RetainedEarningsAccumulatedLosses 2025-02-28 13182333 core:RetainedEarningsAccumulatedLosses 2024-02-29 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 13182333
England and Wales
SWEDISH BIOMIMETICS 3000 UMIST ENTERPRISE LIMITED
Dormant Accounts
Period of accounts Start date: 01 March 2024 End date: 28 February 2025

Swedish Biomimetics 3000 UMist Enterprise Limited Contents Page For the year ended 28 February 2025
Company information | 1
Directors' report | 2
Accountants' report | 3
Income statement | 4
Statement of financial position | 5
Notes to the financial statements | 6
Statement of changes in equity | 7

Swedish Biomimetics 3000 UMist Enterprise Limited Company Information For the year ended 28 February 2025
Directors | PODKOLINSKI Thomas Hayley French
Registered Number | 13182333
Registered Office | c/o Adepta Limited Unit 6, Hill Farm, Kirby Road Norwich Norfolk NR14 7DU
Accountants | Adepta Limited Unit 6, Hill Farm Kirby Road, Kirby Bedon Norwich Norfolk NR14 7DU
1

Swedish Biomimetics 3000 UMist Enterprise Limited Directors' Report For the year ended 28 February 2025
The directors present his/her/their annual report and the financial statements for the year ended 28 February 2025. The company is dormant and has not traded during the year. Directors The directors who served the company throughout the year were as follows:
PODKOLINSKI Thomas
Hayley French
This report was approved by the board and signed on its behalf by:
---------------------------------- Hayley French Director
Date approved: 23 January 2026 2

Swedish Biomimetics 3000 UMist Enterprise Limited Accountants' Report For the year ended 28 February 2025
Report to the directors on the preparation of the unaudited statutory accounts of Swedish Biomimetics 3000 UMist Enterprise Limited for the year ended 28 February 2025. In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Swedish Biomimetics 3000 UMist Enterprise Limited for the year ended 28 February 2025 which comprise of the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the company’s accounting records and from information and explanations you have given us. As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at http://rulebook.accaglobal.com/. This report is made solely to the Board of Directors of Swedish Biomimetics 3000 UMist Enterprise Limited, as a body, in accordance with the terms of our engagement letter dated 23 January 2026. Our work has been undertaken solely to prepare for your approval the accounts of Swedish Biomimetics 3000 UMist Enterprise Limited and state those matters that we have agreed to state to the Board of Directors of Swedish Biomimetics 3000 UMist Enterprise Limited, as a body, in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at http://www.accaglobal.com/factsheet163. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Swedish Biomimetics 3000 UMist Enterprise Limited and its Board of Directors as a body for our work or for this report. It is your duty to ensure that Swedish Biomimetics 3000 UMist Enterprise Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of Swedish Biomimetics 3000 UMist Enterprise Limited. You consider that Swedish Biomimetics 3000 UMist Enterprise Limited is exempt from the statutory audit requirement for the year. We have not been instructed to carry out an audit or a review of the accounts of Swedish Biomimetics 3000 UMist Enterprise Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts 28 February 2025. .................................................... Adepta Limited Unit 6, Hill Farm Kirby Road, Kirby Bedon Norwich Norfolk NR14 7DU 23 January 2026 3

Swedish Biomimetics 3000 UMist Enterprise Limited Income Statement For the year ended 28 February 2025
The company is dormant and has not traded during the year. The company received no income and incurred no expenditure in the year and therefore made neither a profit nor loss. The notes form part of these financial statements. 4

Swedish Biomimetics 3000 UMist Enterprise Limited Statement of Financial Position As at 28 February 2025
| Notes | 2025 £ |  | 2024 £
--- | --- | --- | --- | ---
Current assets |  |  |
Creditors: amount falling due within one year |  | 10 |  | 10
Net current assets |  | 10 |  | 10
Total assets less current liabilities |  | 10 |  | 10
Net assets |  | 10 |  | 10
Capital and reserves |  |  |
Called up share capital |  | 10 |  | 10
Shareholders' funds |  | 10 |  | 10
For the year ended 28 February 2025 the company was entitled to exemption from audit under Section 480 of the Companies Act 2006 relating to dormant companies. Directors' responsibilities: The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies. The financial statements were approved by the board of directors on 23 January 2026 and were signed on its behalf by:
------------------------------- Hayley French Director
5

Swedish Biomimetics 3000 UMist Enterprise Limited Statement of Changes in Equity For the year ended 28 February 2025
|  | Equity share capital |  | Retained Earnings |  | Total
| £ |  | £ |  | £ |
At 01 March 2023 |  | 10 |  |  |  | 10
Total comprehensive income for the year |  | - |  | - |  | -
Total investments by and distributions to owners |  | - |  | - |  | -
At 29 February 2024 |  | 10 |  |  |  | 10
At 01 March 2024 |  | 10 |  |  |  | 10
Total comprehensive income for the year |  | - |  | - |  | -
Total investments by and distributions to owners |  | - |  | - |  | -
At 28 February 2025 |  | 10 |  |  |  | 10
6

Swedish Biomimetics 3000 UMist Enterprise Limited Notes to the Financial Statements For the year ended 28 February 2025
General Information Swedish Biomimetics 3000 UMist Enterprise Limited is a private company, limited by shares, registered in England and Wales, registration number 13182333, registration address c/o Adepta Limited, Unit 6, Hill Farm, Kirby Road, Norwich, Norfolk, NR14 7DU. The presentation currency is £ sterling.
1. | Accounting policies Significant accounting policies Statement of compliance These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006. Basis of preparation The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies. The financial statements are prepared in sterling which is the functional currency of the company.
7